Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and ...
Henry Schein has received a strategic investment of $250 million from KRR, giving the global investment firm a 12% stake in the company, with the option to purchase additional shares ...
In a report released on January 29, Michael Cherny from Leerink Partners reiterated a Hold rating on Henry Schein (HSIC – Research Report), ...
Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz from ...
MELVILLE, N.Y., January 29, 2025--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) ("Henry Schein" or the "Company"), the world’s largest provider of health care ...
Henry Schein said it expects to report earnings and revenue growth in the fourth quarter and forecast further gains in 2025 adjusted earnings, even as it confirmed an activist-investment deal with ...
Henry Schein (NASDAQ:HSIC) announced Wednesday a strategic investment from funds affiliated with private equity firm KKR (NYSE:KKR) and released its preliminary Q4 2024 financials and full-year ...